Delivery Order SPE2DB24D2010-SPE2DB25FZUS7

Award Date 1/22/25
Potential Completion Date 2/12/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,135.20 fixed-price contract with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has a period of performance through January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for comprehensive pharmaceutical and...
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET in quantities of 120 per shipment. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order has a ceiling value of $118,261.86 and an ultimate completion date of October 9, 2024. This contract is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET UU 60S to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $9,774.74, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division on April 15, 2024, with a completion date of May 6, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,271.84, is for the supply of LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of March 14, 2025. The contract is not designated as a set-aside and was awarded as part of a larger Indefinite Delivery Contract...
This federal contract award is a delivery order for LYNPARZA 150 MG TABLET UU 120S, valued at $42,270.40, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans'...
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET UU 120S to the U.S. government. The contract, valued at $9,870.87, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a Delivery Order with a Firm Fixed Price pricing type and was awarded by the Defense agency 97AS - Medical Supply Chain. The contract has an ultimate completion date of May 13, 2024. This award does not have a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,499.34 firm fixed-price delivery order is for the supply of the drug LYNPARZA 150 MG TABLET UU 60S to support military healthcare programs. The contract has an ultimate completion date of April 10, 2025 and was awarded on March 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LYNPARZA 150 MG TABLET UU 60S, a specialty pharmaceutical product. The contract has a firm fixed price of $39,098.88 and a completion date of January 24, 2024. It is a delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,774.74 for the supply of LYNPARZA 150 MG TABLET. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 9, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,749.01 firm fixed-price delivery order is for the supply of LYNPARZA 150 MG TABLET UU 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZUS7
    Delivery Order

This federal contract award is for the delivery of LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,271.84 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 22, 2025, with a completion date of February 12, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/23/25, 9:45 AM